Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...

Patients with left main coronary artery disease who present with ACS fare just as well when treated with PCI as they do with CABG surgery, according to results of a new study. While ACS patients had ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer-reviewed. Various P2Y 12 inhibitors have different efficacies and bleeding risks, and ...

PARIS, France—In patients with ACS and complex lesions, the incidence of adverse events is lower when OCT rather than angiography is used to guide PCI, according to a subanalysis of the OCCUPI trial.

Please provide your email address to receive an email when new articles are posted on . “PCI is the preferred reperfusion strategy in patients presenting with ACS with latest-generation DES ...

"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...

Please provide your email address to receive an email when new articles are posted on . Although researchers could not associate pollen exposure with incident ACS, they did observe elevated ...

Effient tablets are approved by the U.S. Food and Drug Administration to reduce the risk of future heart-related events, such as heart attack or stent thrombosis, in patients with acute coronary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window This was a ...